Abstract: The present disclosure relates generally to the supplementation of butyrate in the diet of mammals. Specifically, the present disclosure relates to a method for supplementing butyrate in the diet of a mammal resulting in improved physiological outcomes through the gut-brain axis, including improvements in anxiety and depression, and other cognitive behaviors, such as brain function, cognitive performance, executive function, stress, sleep, and focus. The present disclosure and methodology demonstrates advantages of administering a direct butyrate generating supplement, to influence the gut-brain axis through two pathways: a first pathway of butyrate generation leading to improvements in gut health which lead to improvements in brain health, and a second pathway of direct butyrate generation in the gut directly leading to improvements in brain health, independent of gut health.

Abstract: The present disclosure relates generally to a composition including a glycoside combined with an edible acid to synergistically enhance the rate or speed of dissolution of the glycoside resulting in improved absorption of the glycoside when the composition is incorporated into various consumable products. The present disclosure relates to improved consumable products including, but not limited to, food/beverage products, pet food and nutritional supplements, beverages, pharmaceutical and nutraceutical formulations, whereby, a combination of a glycoside with an edible acid has been added to the consumable product to enhance the rate or speed of dissolution of the glycoside resulting in improved absorption of a glycoside when the consumable product is ingested.

Abstract: The present disclosure provides a novel supplement composition comprising a 2:1 molar ratio of taurine to malic acid, which can be added to food or beverages, or incorporated as a dietary supplement. The present supplement composition when added to a food, beverage or dietary supplement provides various health benefits, including ergogenic effects of enhanced physical performance, stamina, and recovery, threshold pain reduction, increased power, and increased vasodilation for improved recovery and performance. The present disclosure also provides method of making the composition.

Abstract: The present disclosure provides a novel supplement composition comprising a 2:1 molar ratio of taurine to malic acid, which can be added to food or beverages, or incorporated as a dietary supplement. The present supplement composition when added to a food, beverage or dietary supplement provides various health benefits, including ergogenic effects of enhanced physical performance, stamina, and recovery, threshold pain reduction, increased power, and increased vasodilation for improved recovery and performance.

Abstract: The present disclosure relates to relates to improved dietary supplement compositions formulated in a therapeutic effective amount for enhancing cognitive support and brain health. Specifically, the present disclosure relates to dietary and nutritional supplement compositions administered to a mammal in a therapeutically-effective amount to provide cognitive support and enhance overall brain health. The present disclosure further relates to a method of supporting cognitive health in a mammal comprising administering to the mammal in need thereof a therapeutically effective amount of a nutritional supplement comprising a combination of a carotenoid and an adaptogen.

Abstract: The present disclosure relates generally to dietary supplements and compositions containing Rhodiola crenulata administered in therapeutically effective amounts for effecting health in a mammal. Disclosed are compositions containing an improved extract of Rhodiola crenulata containing a higher content level of salidrosides (>5%), and a reduced number of or absence of other flavonoids. In this manner, the resulting novel composition has enhanced bioactivity of salidroside, and therefore, improved treatment and health benefit possibilities.

Abstract: The present disclosure relates to compositions and methods for helping to manage the lingering symptoms and effects of COVID-19 after recovery. Specifically, the present disclosure relates to sustained release dietary and nutritional supplement compositions and methods to provide ongoing support and symptom management for individuals exposed to SARS-CoV-2 who contacted COVID-19 and later recovered but continue to experience after-effects or lingering symptoms. Specifically, the composition is based on a sustained release ashwagandha extract, alone in a therapeutically effective amount, or in combination with other ingredients.

Abstract: The present disclosure relates to relates to improved dietary supplement compositions formulated in a therapeutic effective amount for enhancing play of electronic video games. Specifically, the present disclosure relates to compositions for oral consumption, in the form of dietary supplements, foods or beverages, which provide fast acting, broad spectrum cognitive enhancing formulas for gaming and video game purposes. The formulas consist of ingredients for enhancing certain parameters to improve gaming abilities, including increased energy and alertness, brain wave function, neurotransmission, reduced stress, improved sleep, improved eye health, improved blood flow, and improved hydration and reduced muscle soreness.

Abstract: The present disclosure relates generally to compositions for a dietary supplement, a food supplement, and/or a nutritional supplement, useful in the generation of butyrate in the gastrointestinal track or gut of a mammal for effecting and improving health and wellness. The present disclosure also relates to the use of a dietary supplement provided in a therapeutically effective amount as a replacement for probiotics and prebiotic usage. Additionally, the present disclosure relates to a dietary supplement composition including a low therapeutic dose of tributyrin either alone, or in combination with prebiotics and/or probiotics to enhance health and wellness. Furthermore, the present disclosure also relates to a low dose dietary supplement composition which generates therapeutic amounts of butyrate in the gut of a mammal independent of the state of the microbiome to achieve desired health benefits of butyrate.

Abstract: The present disclosure relates to compositions and methods for helping to manage the lingering symptoms and effects of COVID-19 after recovery. Specifically, the present disclosure relates to sustained release dietary and nutritional supplement compositions and methods to provide ongoing support and symptom management for individuals exposed to SARS-CoV-2 who contacted COVID-19 and later recovered but continue to experience after-effects or lingering symptoms. Specifically, the composition is based on a sustained release ashwagandha extract, alone in a therapeutically effective amount, or in combination with other ingredients.

Abstract: The present disclosure relates to relates to improved dietary supplement compositions formulated in a therapeutic effective amount for enhancing cognitive support and brain health. Specifically, the present disclosure relates to dietary and nutritional supplement compositions administered to a mammal in a therapeutically-effective amount to provide cognitive support and enhance overall brain health. The present disclosure further relates to a method of supporting cognitive health in a mammal comprising administering to the mammal in need thereof a therapeutically effective amount of a nutritional supplement comprising a combination of a carotenoid and an adaptogen.

Abstract: The present disclosure relates to relates to improved dietary supplement compositions formulated in a therapeutic effective amount for enhancing play of electronic video games. Specifically, the present disclosure relates to compositions for oral consumption, in the form of dietary supplements, foods or beverages, which provide fast acting, broad spectrum cognitive enhancing formulas for gaming and video game purposes. The formulas consist of ingredients for enhancing certain parameters to improve gaming abilities, including increased energy and alertness, brain wave function, neurotransmission, reduced stress, improved sleep, improved eye health, improved blood flow, and improved hydration and reduced muscle soreness.

Abstract: A hydrogen generation device and method are provided. The device includes componentry for separating an input flow of water such as tap water into separate hydrogen enriched and oxygen enriched flows. These flows are then recombined to produce a hydrogen enriched flow with a substantially neutral pH.

Abstract: A composition for energy-controlled generation and release of at least one gas, which includes an energy-activated catalyst capable of being activated by electromagnetic energy, and a solid or a liquid containing anions capable of being oxidized by the activated catalyst or reacted with species generated during activation of the catalyst to generate at least one gas. The composition, when exposed to electromagnetic energy, is capable of generating and releasing the gas after activation of the catalyst and oxidation or reaction of the anions.

Abstract: Abstract of the Disclosure ABSTRACT OF THE DISCLOSURE Gas generating and releasing articles consisting essentially of a polymer and a gas generating solid dispersed therein are described. The article generates and releases a gas in response to moisture and in the absence of an acid, a polymer that degrades to produce an acid, a compound that generates an acid in response to humidity, a hygroscopic compound, and an oxidant. The article may also generate and release a gas in response to energy.

Abstract: Gas generating and releasing articles consisting essentially of a polymer and a gas generating solid dispersed therein are described. The article generates and releases a gas in response to moisture and in the absence of an acid, a polymer that degrades to produce an acid, a compound that generates an acid in response to humidity, a hygroscopic compound, and an oxidant. The article may also generate and release a gas in response to energy.

Abstract: A powder for sustained release of a gas including a core containing a molecular sieve, and a layer containing an acid releasing agent on an outer surface of the core. The core and the layer are substantially free of water, and the core is capable of generating and releasing a gas after hydrolysis of the acid releasing agent.